首页> 外文期刊>Asian Journal of Pharmaceutical and Clinical Research >FORMULATION AND EVALUATION OF GASTRORETENTIVE TABLETS OF ANTIULCER DRUG
【24h】

FORMULATION AND EVALUATION OF GASTRORETENTIVE TABLETS OF ANTIULCER DRUG

机译:止痛药胃肠增效片剂的研制与评价

获取原文
           

摘要

Gastroretentive floating drug delivery system is utilised to target drug release in the stomach or to the upper part of intestine. Lansoprazole is proton pump inhibitor intended for oral administration used as antiulcer agent. The present investigation involved formulation and evaluation of Gastroretentive floating tablets of Lansoprazole for prolongation of gastric residence time with a view to deliver the drug at sustained and controlled manner in gastrointestinal tract. The tablets of Lansoprazole were prepared by direct compression method using gas generating agent and different polymer combinations (HPMCK4M, HPMC K100M, Psyllium husk) . The prepared tablets of Lansoprazole were evaluated for hardness, thickness, friability, weight variation, drug content uniformity, buoyancy lag time, total floating time, swelling index, in-vitro dissolution study. The varying concentration of gas generating agent and polymers were found to affect on in-vitro drug release, floating lag time and swelling index. In vitro drug release of floating Gastroretentive tablet of Lansoprazole shown that the formulation F2 was found to be the best formulation as it releases 97.9% Lansoprazole in a controlled manner for extended period of time (upto 12 hrs.)
机译:胃滞留性浮动药物输送系统用于靶向药物在胃或肠上部的释放。 Lansoprazole是质子泵抑制剂,打算用作抗溃疡剂口服。本研究涉及兰索拉唑胃滞留性漂浮片剂的延长胃停留时间的配制和评价,以期在胃肠道中以可控的方式递送药物。兰索拉唑片剂通过使用气体发生剂和不同的聚合物组合(HPMCK4M,HPMC K100M,欧车前壳)的直接压片法制备。评价制备的兰索拉唑片剂的硬度,厚度,脆性,重量变化,药物含量均匀性,浮力滞后时间,总漂浮时间,溶胀指数,体外溶出度研究。发现气体生成剂和聚合物浓度的变化会影响体外药物释放,漂浮滞后时间和溶胀指数。兰索拉唑漂浮性胃滞留片剂的体外药物释放表明,制剂F2被认为是最好的制剂,因为它以受控方式延长了97.9%的兰索拉唑的释放时间(长达12小时)。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号